Medicare Enrolled
Dr. Waleed El-Feky, M.D.
Neurology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. El-Feky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El-Feky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. El-Feky
Dr. Waleed El-Feky is a neurology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. El-Feky performed 47,193 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. El-Feky received a total of $434,677 from 73 pharmaceutical and/or device companies across 1272 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. El-Feky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in TX
$434,677 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗47,193
Medicare services
Top 2% in TX for neurology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| MRI contrast dye injection (gadoterate) Administration of gadoterate meglumine, a contrast agent, in a 0.1 ml dose. |
20,980 | $0 | $1 |
| Capsaicin pain patch (Qutenza) | 19,600 | $3 | $10 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
4,745 | $5 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
644 | $88 | $330 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
285 | $63 | $225 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
159 | $77 | $102 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
157 | $120 | $500 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
110 | $168 | $1,530 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
72 | $125 | $440 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
62 | $70 | $520 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
50 | $163 | $715 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $75 | $330 |
| New patient office visit, complex (60-74 min) | 36 | $174 | $630 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
35 | $46 | $198 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 34 | $61 | $165 |
| MRI of lower spine, without contrast A magnetic resonance imaging scan of the lower spinal canal that does not use contrast dye to create detailed images of the spine. |
25 | $97 | $990 |
| MRI of head blood vessels without contrast An MRI scan that creates detailed images of the blood vessels in the head without using contrast dye. |
23 | $91 | $1,225 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
22 | $191 | $800 |
| Destruction of peripheral nerve or branch | 21 | $287 | $800 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
20 | $97 | $975 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
18 | $94 | $402 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
17 | $102 | $1,115 |
| MRI of neck blood vessels with and without contrast This procedure uses magnetic resonance imaging to create detailed pictures of the blood vessels in the neck. Images are taken both before and after the administration of a contrast dye to enhance visibility. |
16 | $211 | $1,856 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
11 | $107 | $445 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $39 | $135 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$434,677
Total received (2018-2024)
Avg $62,097/year across 7 years
Top 2% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
1,272
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$201,246
2023
$93,556
2022
$89,819
2021
$17,550
2020
$9,184
2019
$11,140
2018
$12,182
Payments by company (2024)
Averitas Pharma Inc.
$75,771
Ipsen Biopharmaceuticals, Inc
$38,760
Amgen Inc.
$27,980
Lilly USA, LLC
$20,936
Biogen, Inc.
$12,313
E.R. Squibb & Sons, L.L.C.
$10,066
Axsome Therapeutics, Inc.
$5,867
UCB, Inc.
$3,621
JAZZ PHARMACEUTICALS INC.
$3,601
Celgene Corporation
$560
Eisai Inc.
$471
TG Therapeutics, Inc.
$385
ABBVIE INC.
$261
ACADIA Pharmaceuticals Inc
$122
PFIZER INC.
$105
Merz Pharmaceuticals, LLC
$91
Novartis Pharmaceuticals Corporation
$87
Abbott Laboratories
$62
Genentech USA, Inc.
$41
Alexion Pharmaceuticals, Inc.
$29
HOSPIRA, INC.
$26
Teva Pharmaceuticals USA, Inc.
$26
Harmony Biosciences Llc
$24
Inspire Medical Systems, Inc.
$23
Lundbeck LLC
$18
Top 3 companies account for 70.8% of 2024 payments
All-time payments by company (2018-2024) ›
Averitas Pharma Inc.
$110,448
Biogen, Inc.
$53,976
GRT US Holding, Inc.
$53,271
Ipsen Biopharmaceuticals, Inc
$51,528
Amgen Inc.
$28,052
Lilly USA, LLC
$21,187
Allergan, Inc.
$20,701
Allergan Inc.
$19,024
Axsome Therapeutics, Inc.
$17,156
E.R. Squibb & Sons, L.L.C.
$16,682
Horizon Therapeutics plc
$10,551
ABBVIE INC.
$9,115
JAZZ PHARMACEUTICALS INC.
$4,065
UCB, Inc.
$3,942
Acorda Therapeutics, Inc
$2,931
Eli Lilly and Company
$1,400
Sunovion Pharmaceuticals Inc.
$1,111
Celgene Corporation
$1,078
Novartis Pharmaceuticals Corporation
$978
Genentech USA, Inc.
$887
ACADIA Pharmaceuticals Inc
$703
Teva Pharmaceuticals USA, Inc.
$494
Eisai Inc.
$488
GENZYME CORPORATION
$430
TG Therapeutics, Inc.
$385
EMD Serono, Inc.
$378
PFIZER INC.
$362
Merz Pharmaceuticals, LLC
$350
AbbVie Inc.
$327
Alexion Pharmaceuticals, Inc.
$284
Amneal Pharmaceuticals LLC
$154
SK Life Science, Inc.
$138
Biohaven Pharmaceuticals, Inc.
$123
Grifols USA, LLC
$118
ARGENX US, INC.
$108
Kyowa Kirin, Inc.
$104
Lundbeck LLC
$98
CSL Behring
$91
Avanir Pharmaceuticals, Inc.
$86
Avion Pharmaceuticals
$85
Janssen Pharmaceuticals, Inc
$84
Neurocrine Biosciences, Inc.
$82
Sumitomo Pharma America, Inc.
$81
Abbott Laboratories
$76
MERZ NORTH AMERICA, INC.
$67
Siemens Medical Solutions USA, Inc.
$64
Adamas Pharmaceuticals, Inc.
$62
Inspire Medical Systems, Inc.
$60
AbbVie, Inc.
$50
Corium, LLC
$49
TG THERAPEUTICS, INC.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$46
CATALYST PHARMACEUTICALS, INC.
$45
Harmony Biosciences LLC
$45
Biohaven Pharmaceutical Holding Company Ltd.
$45
ARBOR PHARMACEUTICALS, INC.
$37
Mitsubishi Tanabe Pharma America, Inc.
$35
Arbor Pharmaceuticals, Inc.
$35
HARMONY BIOSCIENCES LLC
$32
Merz North America, Inc.
$29
HOSPIRA, INC.
$26
Harmony Biosciences Llc
$24
Alnylam Pharmaceuticals Inc.
$18
Avid Radiopharmaceuticals, Inc.
$17
Medtronic USA, Inc.
$17
Assertio Therapeutics, Inc.
$17
Promius Pharma LLC
$16
GE HEALTHCARE
$15
Greenwich Biosciences, Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$14
Upsher-Smith Laboratories LLC
$13
Supernus Pharmaceuticals, Inc.
$13
Bayer HealthCare Pharmaceuticals Inc.
$11
Top 3 companies account for 50.1% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · BRIUMVI · Betaseron · Briviact · CAMBIA · COPAXONE · Confirm Rx · DAYBUE · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · Fintepla · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · KYNMOBI · LEADPOINT · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ongentys · PANZYGA · POMPE - DISEASE · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RYTARY · Radicava · Rebif · SOLIRIS · SUNOSI · Skyclarys · Sunosi · TECFIDERA · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VERSANT kPCR Molecular System SP · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · XEOMIN · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zinbryta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
241
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT AND WHITE MEDICAL CENTER UPTOWN
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. El-Feky is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. El-Feky experienced with mri contrast dye injection (gadoterate)?
Based on Medicare claims data, Dr. El-Feky performed 20,980 mri contrast dye injection (gadoterate) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. El-Feky receive payments from pharmaceutical companies?
Yes. Dr. El-Feky received a total of $434,677 from 73 companies across 1,272 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El-Feky's costs compare to other neurologists in Dallas?
Dr. El-Feky's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El-Feky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Dallas
Browse neurologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
Averitas Pharma Inc. Payments to Doctors
See all physicians who received payments from Averitas Pharma Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
GRT US Holding, Inc. Payments to Doctors
See all physicians who received payments from GRT US Holding, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology